3-Factor Versus 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Severe Bleeding: A Multicenter,...

Area of Science:

• Hematology
• Pharmacology

Background:

• Current guidelines recommend 4-factor prothrombin complex concentrate (4PCC) for urgent warfarin reversal.
• Direct comparisons between 3-factor prothrombin complex concentrate (3PCC) and 4PCC are limited.
• Warfarin reversal agents are critical in managing bleeding events.

Purpose of the Study:

• To compare the efficacy and safety of 3PCC versus 4PCC for warfarin reversal.
• To evaluate INR normalization rates and thrombotic events associated with both PCC types.

Main Methods:

• Retrospective analysis of patients receiving PCC across four medical centers.
• Propensity-score matching to control for confounding variables.
• Comparison of INR ≤ 1.4 and goal INR achievement between 3PCC and 4PCC groups.

Main Results:

• No significant difference in INR ≤ 1.4 between 3PCC and 4PCC in unmatched and matched cohorts.
• 4PCC showed a statistically significant advantage in achieving goal INR for patients with baseline INR > 4.0.
• Three thrombotic events occurred, all in the 4PCC group, with no statistically significant difference in rates.

Conclusions:

• Both 3PCC and 4PCC demonstrate comparable efficacy in INR reversal.
• 4PCC may offer superior INR normalization for patients with elevated baseline INR (> 4.0).
• Further research is warranted to fully elucidate safety profiles and optimal use cases.